within Pharmacolibrary.Drugs.ATC.L;

model L03AA09
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.007,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.07,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.161,
    k12             = 7.0,
    k21             = 7.0
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L03AA09</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Sargramostim is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) that stimulates the production of neutrophils, monocytes, and macrophages. It is used to accelerate myeloid recovery in patients undergoing bone marrow transplantation, for patients with neutropenia, and as an adjunct in certain infections. Sargramostim is FDA-approved and used clinically in specified hematological conditions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult cancer patients receiving sargramostim intravenously after autologous bone marrow transplantation.</p><h4>References</h4><ol><li><p>Stute, N, et al., &amp; Evans, WE (1995). Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration. <i>Journal of pharmaceutical sciences</i> 84(7) 824–828. DOI:<a href=\"https://doi.org/10.1002/jps.2600840708\">10.1002/jps.2600840708</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7562431/\">https://pubmed.ncbi.nlm.nih.gov/7562431</a></p></li><li><p>Straus, DJ (2002). Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin&#x27;s lymphoma. <i>Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer</i> 159 143–148. DOI:<a href=\"https://doi.org/10.1007/978-3-642-56352-2_17\">10.1007/978-3-642-56352-2_17</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11785838/\">https://pubmed.ncbi.nlm.nih.gov/11785838</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L03AA09;
